PMID- 35515389 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2046-2069 (Electronic) IS - 2046-2069 (Linking) VI - 10 IP - 65 DP - 2020 Oct 27 TI - Integrated glycomics strategy for the evaluation of glycosylation alterations in salivary proteins associated with type 2 diabetes mellitus. PG - 39739-39752 LID - 10.1039/d0ra05466f [doi] AB - Glycosylation is involved in several biological processes, and its alterations can reflect the process of certain diseases. Type 2 diabetes mellitus (T2DM) has attained the status of a global pandemic; however, the difference in salivary protein glycosylation between healthy subjects and patients with T2DM has not been fully understood. In the present study, salivary specimens from patients with T2DM (n = 72) and healthy volunteers (HVs, n = 80) were enrolled and divided into discovery and validation cohorts. A method combining the lectin microarray and lectin blotting was employed to investigate and confirm the altered glycopatterns in salivary glycoproteins. Then, lectin-mediated affinity capture of glycoproteins and MALDI-TOF/TOF-MS were performed to obtain the precise structural information of the altered glycans. As a result, the glycopatterns recognized by 5 lectins (LEL, VVA, Jacalin, RCA120 and DSA) showed significant alteration in the saliva of T2DM patients. Notably, the glycopattern of Galbeta-1,4GlcNAc (LacNAc) recognized by LEL exhibited a significant increase in T2DM patients compared to HVs in both discovery and validation cohorts. The MALDI-TOF/TOF-MS results indicated that there were 10 and 7 LacNAc-containing N/O-glycans (e.g. m/z 1647.586, 11 688.613 and 1562.470) that were identified only in T2DM patients. Besides, the relative abundance of 3 LacNAc-containing N-glycans and 10 LacNAc-containing O-glycans showed an increase in the glycopattern in T2DM patients. These results indicated that the glycopattern of LacNAc is increased in salivary glycoproteins from T2DM patients, and an increase in LacNAc-containing N/O-glycans may contribute to this alteration. Our findings provide useful information to understand the complex physiological changes in the T2DM patients. CI - This journal is (c) The Royal Society of Chemistry. FAU - Yu, Hanjie AU - Yu H AUID- ORCID: 0000-0003-2684-8715 AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Wang, Junhong AU - Wang J AD - Department of Endocrinology, Second Affiliated Hospital of Xi'an Jiaotong University Xi'an 710004 China. FAU - Tang, Zhen AU - Tang Z AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Li, Xia AU - Li X AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Yin, Mengqi AU - Yin M AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Zhang, Fan AU - Zhang F AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Shu, Jian AU - Shu J AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Chen, Wentian AU - Chen W AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. FAU - Yang, Shuang AU - Yang S AUID- ORCID: 0000-0001-7958-0594 AD - Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Soochow University Suzhou Jiangsu China Yangs2020@suda.edu.cn. FAU - Li, Zheng AU - Li Z AD - Laboratory for Functional Glycomics, College of Life Sciences, Northwest University No. 229 Taibai Beilu Xi'an 710069 China zhengli@nwu.edu.cn. LA - eng PT - Journal Article DEP - 20201101 PL - England TA - RSC Adv JT - RSC advances JID - 101581657 PMC - PMC9057417 COIS- The authors declare no conflict of interest. EDAT- 2020/11/01 00:00 MHDA- 2020/11/01 00:01 PMCR- 2020/11/01 CRDT- 2022/05/06 05:35 PHST- 2020/06/22 00:00 [received] PHST- 2020/10/10 00:00 [accepted] PHST- 2022/05/06 05:35 [entrez] PHST- 2020/11/01 00:00 [pubmed] PHST- 2020/11/01 00:01 [medline] PHST- 2020/11/01 00:00 [pmc-release] AID - d0ra05466f [pii] AID - 10.1039/d0ra05466f [doi] PST - epublish SO - RSC Adv. 2020 Nov 1;10(65):39739-39752. doi: 10.1039/d0ra05466f. eCollection 2020 Oct 27.